Item 2.02. Results of Operations and Financial Condition.

On January 10, 2022, Avita Medical, Inc. (the "Company"), announced preliminary unaudited results for the quarter ended December 31, 2021 and certain other business updates. A copy of a press release announcing same is furnished herewith as Exhibit 99.1 to this report.

Item 7.01. Regulation FD Disclosure.

On January 11, 2022, the Company participated in the 40th Annual J.P. Morgan Healthcare Conference. During the presentation, representatives of the Company presented slides, attached hereto as Exhibit 99.2.

The information under these Items 2.02, 7.01, and in Item 9.01 below are being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.



Exhibit No.    Description

   99.1          AVITA Medical Announces Preliminary Unaudited Results for the
               Quarter Ended December 31, 2021

   99.2          JP Morgan Healthcare Conference Presentation

EXHIBIT 104    Cover Page Interactive Data File (embedded within the Inline XBRL
               document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses